scispace - formally typeset
S

Shizuo Akira

Researcher at Osaka University

Publications -  1330
Citations -  344469

Shizuo Akira is an academic researcher from Osaka University. The author has contributed to research in topics: Innate immune system & Immune system. The author has an hindex of 261, co-authored 1308 publications receiving 320561 citations. Previous affiliations of Shizuo Akira include University of California, Berkeley & Wakayama Medical University.

Papers
More filters
Journal ArticleDOI

Both IL‐12 and IL‐18 contribute to small intestinal Th1‐type immunopathology following oral infection with Toxoplasma gondii, but IL‐12 is dominant over IL‐18 in parasite control

TL;DR: Results reveal that both IL‐12 and IL‐18 play an important role in the development of intestinal immunopathology following oral infection with T. gondii, and neutralization ofIL‐18 (rather than TNF‐α, IL‐ 12, and IFN‐γ) may be a safe strategy for the treatment of Th1‐associated diseases.
Journal ArticleDOI

Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous Leishmania major Infection

TL;DR: The results indicate that despite the role IL-18 may play in early control of cutaneous L. major lesion growth, this cytokine is not critical for development of protective Th1 response and resolution of L.major infection.
Journal ArticleDOI

Cutting Edge: Pivotal function of Ubc13 in thymocyte TCR signaling.

TL;DR: Ubc13 plays an important role in thymocyte TCR-mediated signaling and immune responses and PMA/ionophore-mediated ubiquitination of NF-κB essential modulator (NEMO)/IκB kinase γ (IKKγ) and phosphorylation of TGF-β-activated kinase 1 (TAK1) were nearly abolished in Ubc13-deficient thymocytes.
Journal ArticleDOI

Positive Feedback Within a Kinase Signaling Complex Functions as a Switch Mechanism for NF-κB Activation

TL;DR: It is shown that the CARD-containing MAGUK protein 1 (CARMA1, also called CARD11)–TAK1 (MAP3K7)–inhibitor of NF-κB (IκB) kinase-β (IKKβ) module is a switch mechanism for NF-σκB activation in B cell receptor (BCR) signaling, and IKK activity is regulated by positive feedback from IKKβ to TAK1.